Given the multicystic ovarian stroma commonly present in PCOS, it is not surprising that relatively higher serum AMH levels in PCOS patients compared to age- and weight-matched ovulatory (i.e., non-PCOS) controls have been observed, suggesting its potential use as a diagnostic tool for PCOS. This evidence concerns the gene AMH and polycystic ovary syndrome.